Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| IONIS PHARMACEUTICALS INCIONS · Entity 1182 | Director | December 01, 2025 | December 04, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
IONIS PHARMACEUTICALS INC
Report date December 01, 2025 · Filed December 04, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Indirectby Trust | 43,464 |
Reported balance
After 2025-12-01 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2025-12-01 · Sale · Disposed 20,571 · Balance 43,464 F1: Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 26, 2024. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.11 to $81.11 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4. |
| Common StockSEC Table I · non-derivative | Indirectby Trust | 36,035 |
Reported balance
After 2025-12-01 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2025-12-01 · Sale · Disposed 7,429 · Balance 36,035 F1: Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 26, 2024. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.12 to $81.435 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4. |
| Common StockSEC Table I · non-derivative | Direct | 16,000 |
Reported balance
Holding disclosure · report date 2025-12-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 16,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 26, 2024.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.11 to $81.11 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.12 to $81.435 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
OUTFRONT Media Inc.
Report date June 03, 2025 · Filed June 05, 2025
Section 16 reporting ended · disclosed 2025-06-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 69,225 |
Reported balance
After 2025-06-03 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-06-03 · Exercise / conversion · Acquired 10,125 · Balance 69,225 F1: The restricted share units are settled by delivery of a corresponding number of shares of common stock of OUTFRONT Media Inc. (the "Company") upon vesting. F2: Total shares of the Company's common stock reflect the impact of the common stock portion of the Company's special dividend paid on December 31, 2024, and the reverse stock split on the Company's common stock effectuated on January 17, 2025. |
| Common StockSEC Table I · non-derivative | Direct | 69,996 |
Reported balance
After 2025-06-03 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2025-06-03 · Grant · Acquired 771 · Balance 69,996 F3: Includes shares acquired due to the settlement of dividend equivalents into shares of the Company's common stock at vesting. |
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-06-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-06-03 · Exercise / conversion · Disposed 10,125 · Balance 0 F1: The restricted share units are settled by delivery of a corresponding number of shares of common stock of OUTFRONT Media Inc. (the "Company") upon vesting. F4: These restricted share units vest in full on June 3, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted share units are settled by delivery of a corresponding number of shares of common stock of OUTFRONT Media Inc. (the "Company") upon vesting.
F2: Total shares of the Company's common stock reflect the impact of the common stock portion of the Company's special dividend paid on December 31, 2024, and the reverse stock split on the Company's common stock effectuated on January 17, 2025.
F3: Includes shares acquired due to the settlement of dividend equivalents into shares of the Company's common stock at vesting.
F4: These restricted share units vest in full on June 3, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 08, 2022 Filed Jun 9, 2022 16:20 UTC | OUTFRONT Media Inc. OUT · Entity 3880 | Exercise / conversionCommon Stock | 4,907 | $0.00 | $0.00 |
DisclosureSEC source: 0001579877-22-000063 · wf-form4_165480602357038.xml · nonDerivative · entry 1 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,802 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted share units are settled by delivery of a corresponding number of shares of common stock of OUTFRONT Media Inc. (the "Company") upon vesting. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 16:20 UTC | OUTFRONT Media Inc. OUT · Entity 3880 | GrantRestricted Share Units · Derivative | 7,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001579877-22-000063 · wf-form4_165480602357038.xml · derivative · entry 3 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,290 Underlying: Common Stock · 7,290 shares Expires not disclosed F1 · derivative.exercise_price: The restricted share units are settled by delivery of a corresponding number of shares of common stock of OUTFRONT Media Inc. (the "Company") upon vesting. F3 · derivative.exercise_date: These restricted share units vest in full on June 7, 2023. F3 · derivative.expiration_date: These restricted share units vest in full on June 7, 2023. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 00:17 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionRestricted Stock Unit · Derivative | 1,778 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-21-000141 · edgardoc.xml · derivative · entry 8 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,775 Underlying: Common Stock · 1,778 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F4 · derivative.exercise_date: Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. F4 · derivative.expiration_date: Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 00:17 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionRestricted Stock Unit · Derivative | 666 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-21-000141 · edgardoc.xml · derivative · entry 7 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,553 Underlying: Common Stock · 666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F4 · derivative.exercise_date: Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. F4 · derivative.expiration_date: Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 00:17 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionRestricted Stock Unit · Derivative | 889 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-21-000141 · edgardoc.xml · derivative · entry 6 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,219 Underlying: Common Stock · 889 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F4 · derivative.exercise_date: Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. F4 · derivative.expiration_date: Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 00:17 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionRestricted Stock Unit · Derivative | 5,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-21-000141 · edgardoc.xml · derivative · entry 5 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,108 Underlying: Common Stock · 5,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F3 · derivative.exercise_date: Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. F3 · derivative.expiration_date: Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 00:17 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionCommon Stock | 1,778 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-21-000141 · edgardoc.xml · nonDerivative · entry 4 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 96,971 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award. F1 · shares: Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 00:17 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionCommon Stock | 666 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-21-000141 · edgardoc.xml · nonDerivative · entry 3 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 95,193 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award. F1 · shares: Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 00:17 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionCommon Stock | 889 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-21-000141 · edgardoc.xml · nonDerivative · entry 2 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 94,527 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award. F1 · shares: Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 00:17 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionCommon Stock | 5,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-21-000141 · edgardoc.xml · nonDerivative · entry 1 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 93,638 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award. F1 · shares: Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 21:52 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | GrantRestricted Stock Unit · Derivative | 5,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-21-000119 · edgardoc.xml · derivative · entry 2 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,441 Underlying: Common Stock · 5,333 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F3 · derivative.exercise_date: Grant of July 1, 2021 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2021. F3 · derivative.expiration_date: Grant of July 1, 2021 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2021. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 21:52 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $40.05 | $0.00 |
DisclosureSEC source: 0000874015-21-000119 · edgardoc.xml · derivative · entry 1 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2031-06-30 F1 · derivative.exercise_date: Grant of July 1, 2021 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2021. F1 · derivative.expiration_date: Grant of July 1, 2021 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2021. Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 20:25 UTC | OUTFRONT Media Inc. OUT · Entity 3880 | Exercise / conversionRestricted Share Units · Derivative | 6,366 | $0.00 | $0.00 |
DisclosureSEC source: 0001579877-21-000064 · wf-form4_162328473178879.xml · derivative · entry 3 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,366 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted share units are settled by delivery of a corresponding number of shares of common stock of OUTFRONT Media Inc. upon vesting. F3 · derivative.exercise_date: These restricted share units vest in full on June 8, 2021. F3 · derivative.expiration_date: These restricted share units vest in full on June 8, 2021. Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 20:25 UTC | OUTFRONT Media Inc. OUT · Entity 3880 | GrantRestricted Share Units · Derivative | 4,907 | $0.00 | $0.00 |
DisclosureSEC source: 0001579877-21-000064 · wf-form4_162328473178879.xml · derivative · entry 2 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,907 Underlying: Common Stock · 4,907 shares Expires not disclosed F1 · derivative.exercise_price: The restricted share units are settled by delivery of a corresponding number of shares of common stock of OUTFRONT Media Inc. upon vesting. F2 · derivative.exercise_date: These restricted share units vest in full on June 8, 2022. F2 · derivative.expiration_date: These restricted share units vest in full on June 8, 2022. Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 20:25 UTC | OUTFRONT Media Inc. OUT · Entity 3880 | Exercise / conversionCommon Stock | 6,366 | $0.00 | $0.00 |
DisclosureSEC source: 0001579877-21-000064 · wf-form4_162328473178879.xml · nonDerivative · entry 1 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted share units are settled by delivery of a corresponding number of shares of common stock of OUTFRONT Media Inc. upon vesting. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 21:45 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionDirector Stock Option (right to buy) · Derivative | 11,250 | $0.00 Strike: $28.47 | $0.00 |
DisclosureSEC source: 0000874015-20-000129 · edgar.xml · derivative · entry 4 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,250 shares Expires 2023-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 21:45 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionDirector Stock Option (right to buy) · Derivative | 11,250 | $0.00 Strike: $12.94 | $0.00 |
DisclosureSEC source: 0000874015-20-000129 · edgar.xml · derivative · entry 3 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,250 shares Expires 2022-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 21:45 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionCommon Stock | 11,250 | $28.47 | $320,287.50 |
DisclosureSEC source: 0000874015-20-000129 · edgar.xml · nonDerivative · entry 2 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Joseph H. Wender Trust Disclosed balance after: 88,305 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired as a result of exercising a stock option. F1 · shares: Acquired as a result of exercising a stock option. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 21:45 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionCommon Stock | 11,250 | $12.94 | $145,575.00 |
DisclosureSEC source: 0000874015-20-000129 · edgar.xml · nonDerivative · entry 1 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Joseph H. Wender Trust Disclosed balance after: 77,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired as a result of exercising a stock option. F1 · shares: Acquired as a result of exercising a stock option. Read SEC document |
| July 06, 2020 Filed Jul 6, 2020 21:26 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionRestricted Stock Units · Derivative | 667 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-20-000092 · edgar.xml · derivative · entry 8 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666 Underlying: Common Stock · 667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F3 · derivative.exercise_date: These Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. F3 · derivative.expiration_date: These Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 06, 2020 Filed Jul 6, 2020 21:26 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionCommon Stock | 667 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-20-000092 · edgar.xml · nonDerivative · entry 4 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Joseph H. Wender Trust Disclosed balance after: 65,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards. F1 · shares: Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards. Read SEC document |
| July 02, 2020 Filed Jul 6, 2020 21:26 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionRestricted Stock Units · Derivative | 889 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-20-000092 · edgar.xml · derivative · entry 7 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,777 Underlying: Common Stock · 889 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F3 · derivative.exercise_date: These Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. F3 · derivative.expiration_date: These Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 02, 2020 Filed Jul 6, 2020 21:26 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionCommon Stock | 889 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-20-000092 · edgar.xml · nonDerivative · entry 3 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Joseph H. Wender Trust Disclosed balance after: 65,138 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards. F1 · shares: Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 21:26 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | GrantDirector Stock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $60.20 | $0.00 |
DisclosureSEC source: 0000874015-20-000092 · edgar.xml · derivative · entry 10 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2030-06-30 F5 · derivative.exercise_date: Grant of July 1, 2020 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2020. F5 · derivative.expiration_date: Grant of July 1, 2020 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2020. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 21:26 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | GrantRestricted Stock Units · Derivative | 5,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-20-000092 · edgar.xml · derivative · entry 9 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,333 Underlying: Common Stock · 5,333 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F4 · derivative.exercise_date: Grant of July 1, 2020 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2020. F4 · derivative.expiration_date: Grant of July 1, 2020 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2020. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 21:26 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionRestricted Stock Units · Derivative | 1,778 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-20-000092 · edgar.xml · derivative · entry 6 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,332 Underlying: Common Stock · 1,778 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F3 · derivative.exercise_date: These Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. F3 · derivative.expiration_date: These Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 21:26 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionRestricted Stock Units · Derivative | 666 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-20-000092 · edgar.xml · derivative · entry 5 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F3 · derivative.exercise_date: These Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. F3 · derivative.expiration_date: These Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 21:26 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionCommon Stock | 1,778 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-20-000092 · edgar.xml · nonDerivative · entry 2 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Joseph H. Wender Trust Disclosed balance after: 64,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards. F1 · shares: Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 21:26 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionCommon Stock | 666 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-20-000092 · edgar.xml · nonDerivative · entry 1 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Joseph H. Wender Trust Disclosed balance after: 62,471 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards. F1 · shares: Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards. Read SEC document |
| June 10, 2020 Filed Jun 10, 2020 20:48 UTC | OUTFRONT Media Inc. OUT · Entity 3880 | Exercise / conversionRestricted Share Units · Derivative | 4,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001579877-20-000078 · wf-form4_159183648856779.xml · derivative · entry 4 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,610 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted share units are settled by delivery of a corresponding number of shares of common stock of OUTFRONT Media Inc. (the "Company") upon vesting. F4 · derivative.exercise_date: These restricted share units vest in full on June 10, 2020. F4 · derivative.expiration_date: These restricted share units vest in full on June 10, 2020. F5 · balance_after: Total has been updated to reflect actual number of restricted share units held as compared to amounts reported in the prior year's Form 4 filing for the reporting person. Read SEC document |
| June 10, 2020 Filed Jun 10, 2020 20:48 UTC | OUTFRONT Media Inc. OUT · Entity 3880 | GrantCommon Stock | 312 | $0.00 | $0.00 |
DisclosureSEC source: 0001579877-20-000078 · wf-form4_159183648856779.xml · nonDerivative · entry 2 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,529 F2 · kind: Includes shares acquired due to the settlement of dividend equivalents into shares of the Company's common stock at vesting. F2 · price: Includes shares acquired due to the settlement of dividend equivalents into shares of the Company's common stock at vesting. Read SEC document |
| June 10, 2020 Filed Jun 10, 2020 20:48 UTC | OUTFRONT Media Inc. OUT · Entity 3880 | Exercise / conversionCommon Stock | 4,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001579877-20-000078 · wf-form4_159183648856779.xml · nonDerivative · entry 1 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,217 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted share units are settled by delivery of a corresponding number of shares of common stock of OUTFRONT Media Inc. (the "Company") upon vesting. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:48 UTC | OUTFRONT Media Inc. OUT · Entity 3880 | GrantRestricted Share Units · Derivative | 6,366 | $0.00 | $0.00 |
DisclosureSEC source: 0001579877-20-000078 · wf-form4_159183648856779.xml · derivative · entry 3 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,366 Underlying: Common Stock · 6,366 shares Expires not disclosed F1 · derivative.exercise_price: The restricted share units are settled by delivery of a corresponding number of shares of common stock of OUTFRONT Media Inc. (the "Company") upon vesting. F3 · derivative.exercise_date: These restricted share units vest in full on June 8, 2021. F3 · derivative.expiration_date: These restricted share units vest in full on June 8, 2021. Read SEC document |
| July 03, 2019 Filed Jul 3, 2019 22:34 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionRestricted Stock Units · Derivative | 667 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-19-000093 · edgar.xml · derivative · entry 8 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,333 Underlying: Common Stock · 667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F3 · derivative.exercise_date: Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. F3 · derivative.expiration_date: Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 03, 2019 Filed Jul 3, 2019 22:34 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionCommon Stock | 667 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-19-000093 · edgar.xml · nonDerivative · entry 4 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Joseph H. Wender Trust Disclosed balance after: 61,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards. These shares were issued to the Joseph H. Wender Trust. F1 · shares: Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards. These shares were issued to the Joseph H. Wender Trust. Read SEC document |
| July 02, 2019 Filed Jul 3, 2019 22:34 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionRestricted Stock Units · Derivative | 889 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-19-000093 · edgar.xml · derivative · entry 7 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,666 Underlying: Common Stock · 889 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F3 · derivative.exercise_date: Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. F3 · derivative.expiration_date: Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 02, 2019 Filed Jul 3, 2019 22:34 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionCommon Stock | 889 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-19-000093 · edgar.xml · nonDerivative · entry 3 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Joseph H. Wender Trust Disclosed balance after: 61,138 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards. These shares were issued to the Joseph H. Wender Trust. F1 · shares: Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards. These shares were issued to the Joseph H. Wender Trust. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 22:34 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | GrantDirector Stock Option (right to buy) · Derivative | 16,000 | $0.00 Strike: $64.80 | $0.00 |
DisclosureSEC source: 0000874015-19-000093 · edgar.xml · derivative · entry 10 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2029-06-30 F5 · derivative.exercise_date: Grant of July 1, 2019 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, the first installment vesting on July 1, 2020. The option shall be fully vested and exercisable on July 1, 2023. The option is exercisable to 0 shares on July 1, 2019. F5 · derivative.expiration_date: Grant of July 1, 2019 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, the first installment vesting on July 1, 2020. The option shall be fully vested and exercisable on July 1, 2023. The option is exercisable to 0 shares on July 1, 2019. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 22:34 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | GrantRestricted Stock Units · Derivative | 7,110 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-19-000093 · edgar.xml · derivative · entry 9 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,110 Underlying: Common Stock · 7,110 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F4 · derivative.exercise_date: Grant of July 1, 2019 to reporting person of Restricted Stock Unit Award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on July 1, 2020. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 1, 2023. The RSU is vested as to 0 shares on July 1, 2019. F4 · derivative.expiration_date: Grant of July 1, 2019 to reporting person of Restricted Stock Unit Award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on July 1, 2020. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 1, 2023. The RSU is vested as to 0 shares on July 1, 2019. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 22:34 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionRestricted Stock Units · Derivative | 667 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-19-000093 · edgar.xml · derivative · entry 6 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666 Underlying: Common Stock · 667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F3 · derivative.exercise_date: Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. F3 · derivative.expiration_date: Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 22:34 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionRestricted Stock Units · Derivative | 666 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-19-000093 · edgar.xml · derivative · entry 5 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F3 · derivative.exercise_date: Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. F3 · derivative.expiration_date: Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 22:34 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionCommon Stock | 667 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-19-000093 · edgar.xml · nonDerivative · entry 2 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Joseph H. Wender Trust Disclosed balance after: 60,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards. These shares were issued to the Joseph H. Wender Trust. F1 · shares: Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards. These shares were issued to the Joseph H. Wender Trust. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 22:34 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionCommon Stock | 666 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-19-000093 · edgar.xml · nonDerivative · entry 1 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Joseph H. Wender Trust Disclosed balance after: 59,582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards. These shares were issued to the Joseph H. Wender Trust. F1 · shares: Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards. These shares were issued to the Joseph H. Wender Trust. Read SEC document |
| June 11, 2019 Filed Jun 11, 2019 19:16 UTC | OUTFRONT Media Inc. OUT · Entity 3880 | Exercise / conversionRestricted Share Units · Derivative | 6,018 | $0.00 | $0.00 |
DisclosureSEC source: 0001579877-19-000071 · wf-form4_156029500092998.xml · derivative · entry 4 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,610 Underlying: Common Stock · 6,018 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted share units are settled by delivery of a corresponding number of shares of common stock of OUTFRONT Media Inc. (the "Company") upon vesting. F4 · derivative.exercise_date: These restricted share units vest in full on June 11, 2019. F4 · derivative.expiration_date: These restricted share units vest in full on June 11, 2019. Read SEC document |
| June 11, 2019 Filed Jun 11, 2019 19:16 UTC | OUTFRONT Media Inc. OUT · Entity 3880 | GrantCommon Stock | 254 | $0.00 | $0.00 |
DisclosureSEC source: 0001579877-19-000071 · wf-form4_156029500092998.xml · nonDerivative · entry 2 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,607 F2 · kind: Includes shares acquired due to the settlement of dividend equivalents into shares of the Company's common stock at vesting. F2 · price: Includes shares acquired due to the settlement of dividend equivalents into shares of the Company's common stock at vesting. Read SEC document |
| June 11, 2019 Filed Jun 11, 2019 19:16 UTC | OUTFRONT Media Inc. OUT · Entity 3880 | Exercise / conversionCommon Stock | 6,018 | $0.00 | $0.00 |
DisclosureSEC source: 0001579877-19-000071 · wf-form4_156029500092998.xml · nonDerivative · entry 1 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,353 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted share units are settled by delivery of a corresponding number of shares of common stock of OUTFRONT Media Inc. (the "Company") upon vesting. Read SEC document |
| June 10, 2019 Filed Jun 11, 2019 19:16 UTC | OUTFRONT Media Inc. OUT · Entity 3880 | GrantRestricted Share Units · Derivative | 4,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001579877-19-000071 · wf-form4_156029500092998.xml · derivative · entry 3 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,628 Underlying: Common Stock · 4,610 shares Expires not disclosed F1 · derivative.exercise_price: The restricted share units are settled by delivery of a corresponding number of shares of common stock of OUTFRONT Media Inc. (the "Company") upon vesting. F3 · derivative.exercise_date: These restricted share units vest in full on June 10, 2020. F3 · derivative.expiration_date: These restricted share units vest in full on June 10, 2020. Read SEC document |
| March 19, 2019 Filed Mar 20, 2019 22:05 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | SaleCommon Stock | 10,000 | $79.63 | $796,258.00 |
DisclosureSEC source: 0000874015-19-000053 · edgar.xml · nonDerivative · entry 1 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Joseph H. Wender Trust Disclosed balance after: 58,916 F1 · kind: The sale was made pursuant to shares owned. F1 · shares: The sale was made pursuant to shares owned. Read SEC document |
| July 17, 2018 Filed Jul 19, 2018 22:45 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionNon-Employee Director Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $9.30 | $0.00 |
DisclosureSEC source: 0000874015-18-000101 · edgar.xml · derivative · entry 4 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2021-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 17, 2018 Filed Jul 19, 2018 22:45 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionNon-Employee Director Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $9.22 | $0.00 |
DisclosureSEC source: 0000874015-18-000101 · edgar.xml · derivative · entry 3 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2022-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.